Abstract
Abstract This paper examines national environmental factors responsible for achieving global competitiveness in the pharmaceutical industry. The effect of national economic and regulatory environments on pharmaceutical market and industry structure is empirically tested using a sample consisting of both industrialized and developing countries. GNP was found to be a significant variable affecting market size, industry focus, and industry concentration. Price regulation had a significant negative effect on market demand for pharmaceuticals whereas approval time for new drugs was found to have no significant effect. Results provide important implications for public policy and global strategy.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
